What Is the Afib Symbol on a Blood Pressure Monitor?

The AFib symbol on a blood pressure monitor is a small icon, usually a heart with an irregular line or the letters “AFib” or “AFIB,” that appears on the screen when the device’s algorithm detects a pulse pattern consistent with atrial fibrillation during a reading. It means the monitor noticed something unusual about the rhythm of your heartbeat while it was inflating and deflating the cuff, and it is flagging that irregularity for your attention. The symbol is not a diagnosis, but it is more than a random blip, and understanding what triggers it, how reliable it is, and what you should do about it can save you a lot of unnecessary worry or, in rarer cases, prompt a genuinely important medical visit.

How the Monitor Detects an Irregular Rhythm

Home blood pressure monitors use a method called oscillometry. As the cuff inflates and slowly deflates, a sensor picks up tiny pressure waves created each time your heart pushes blood through the artery in your arm. Normally those waves arrive at fairly even intervals, like a metronome. The monitor uses the timing and size of those waves to calculate your systolic and diastolic pressure and your heart rate.

An AFib detection algorithm looks at the spacing between those pressure pulses. In one widely used approach, the device counts how many pulse-to-pulse intervals vary by more than 15 percent from the average interval across the entire reading. If more than 20 percent of the pulses cross that threshold, the monitor flags the reading as potentially irregular and displays the AFib or irregular heartbeat symbol.¹ That 15-and-20 percent rule is a simplified version of what a cardiologist does when reading an electrocardiogram: looking for rhythm that is “irregularly irregular,” the hallmark of atrial fibrillation.

IHB Symbols Versus Dedicated AFib Symbols

Not every blinking heart icon on a blood pressure monitor means “atrial fibrillation.” Many monitors, even inexpensive ones, display an IHB symbol, short for Irregular HeartBeat. The IHB indicator is more generic. It lights up whenever the device notices any pulse irregularity, which could be a harmless premature beat (the kind many healthy people have), an ectopic beat from caffeine or stress, or genuine atrial fibrillation. If your monitor’s manual refers only to “IHB” and does not mention atrial fibrillation specifically, the device is casting a wide net.

A dedicated AFib indicator is different. Monitors from manufacturers like Microlife, Omron, and Withings that carry a specific AFib-detection algorithm have been designed and tested to distinguish atrial fibrillation from other, less concerning rhythm irregularities. These devices typically show a distinct symbol, sometimes a heart with the letters “AFIB” or “AF,” separate from the generic IHB icon. The algorithm behind that dedicated symbol has been validated against simultaneous electrocardiograms in clinical studies, and the device’s packaging or regulatory documentation will say so. If your monitor only mentions “IHB” and you are concerned about atrial fibrillation screening, check the product’s manual or website to see whether it has passed a validated AFib protocol.

How Accurate Are These Alerts?

The accuracy of home blood pressure monitors at catching atrial fibrillation has been tested in a number of clinical studies, and the results vary depending on the brand, the algorithm generation, and how the study was designed. The numbers are encouraging but not perfect.

In a study using an earlier Microlife device, a single measurement had about 93 percent sensitivity and 89 percent specificity for detecting AFib. When patients took three readings and the monitor required at least two of those three to flag AFib, sensitivity rose to 100 percent and specificity stayed at 89 percent.² In other words, the more readings you take, the better the device gets at separating real atrial fibrillation from random noise.

A more recent head-to-head comparison tested a newer Omron machine-learning algorithm against Microlife’s established approach. The Omron device achieved roughly 95 percent sensitivity and nearly 99 percent specificity, while the Microlife device in the same study had about 79 percent sensitivity and 98 percent specificity.³ That gap matters: a lower sensitivity means the device misses more real cases. A separate study of another device found that all 20 patients with confirmed AFib were correctly identified, giving 100 percent sensitivity, but 12 people without AFib were incorrectly flagged, yielding a specificity of about 85 percent and overall accuracy around 88 percent.⁴

The pattern across studies is consistent: these monitors are quite good at catching AFib when it is present (high sensitivity), but they produce a noticeable number of false positives (moderate specificity). If the symbol appears on your screen, the odds are real that something is going on, but it could also be a false alarm. That is exactly why the symbol is a screening prompt, not a diagnosis.

Why False Positives Happen

False positives, where the symbol lights up even though your heart is actually in a normal rhythm, are the most common frustration people experience with these devices. Several things can cause them.

Body movement: If you shift your arm, fidget, or talk during the reading, the cuff picks up extra pressure oscillations that can mimic irregular heartbeats. One study found that when readings where body movement was detected were excluded, the device’s specificity improved noticeably, from about 85 percent to nearly 90 percent.⁴
Frequent premature beats: People who have a lot of premature atrial or ventricular contractions, the harmless “skipped beat” feeling, can trigger the alarm. In the early Microlife validation study, all five false-positive cases were people whose heartbeats showed irregularities in roughly half of their beats, even though those irregularities were not atrial fibrillation.²
Cuff fit and position: A loose cuff, a cuff placed over clothing, or an arm that is not at heart level can all introduce noise into the pressure signal.
Atrial flutter: This is a different arrhythmia from atrial fibrillation, and while it can also be clinically meaningful, it sometimes looks similar enough to confuse an oscillometric algorithm.

The practical takeaway: if the AFib symbol appears once while you were adjusting your sleeve or reaching for your phone, take another reading in a relaxed, still position before drawing any conclusions. Most manufacturer instructions recommend at least two or three consecutive readings for exactly this reason.

What to Do When the Symbol Appears

A single AFib alert is not an emergency. Here is a practical approach. First, sit quietly for a couple of minutes with your arm resting on a flat surface at roughly heart height, then take another reading. If the symbol does not reappear, the first reading was likely triggered by movement or a stray premature beat, and you can move on with your day.

If the symbol appears on two or more consecutive readings taken under good conditions, that result deserves follow-up with a doctor. You do not need to rush to an emergency room unless you are also experiencing symptoms like a pounding or fluttering chest, dizziness, shortness of breath, or near-fainting. In most cases, the right step is to schedule an appointment with your primary care doctor or cardiologist, who can order a clinical ECG or a longer-duration heart monitor to confirm or rule out atrial fibrillation. The home blood pressure monitor’s role is to prompt that visit, not to replace it.⁵

Write down the date and time of any readings that triggered the symbol, along with the blood pressure and heart rate the device reported. This log can be extremely helpful for your doctor, especially because atrial fibrillation often comes and goes. A brief episode that happened at 7 a.m. during your morning reading might not be detectable on a 10-second ECG done during a 2 p.m. office visit.

Why Catching Atrial Fibrillation Early Matters

Atrial fibrillation raises the risk of stroke because the irregular rhythm allows blood to pool and form clots in the upper chambers of the heart. When one of those clots escapes to the brain, the result is a stroke. The treatment, usually a blood-thinning medication, is well established and dramatically reduces that stroke risk. The problem is that many people with AFib have no noticeable symptoms. Their heart slips in and out of the irregular rhythm without them feeling a thing, which means the first sign of trouble can be the stroke itself.

A study that had high-risk patients screen for AFib while taking daily blood pressure readings at home found that two participants with no prior history of AFib were detected by the monitor and confirmed by ECG, and one was started on blood-thinning therapy as a result.⁶ That is the real appeal of these monitors: they give people who already check their blood pressure every day a passive screening tool for a condition they might never feel.

The evidence on whether large-scale AFib screening actually prevents strokes is more complex than the concept sounds. A meta-analysis pooling data from randomized trials found that screening was associated with a small reduction in stroke or systemic embolism, roughly 7 percent in relative terms, though the result was only marginally statistically significant.⁷ Translating that into absolute numbers, for every 148 people screened, roughly one stroke was prevented over a decade. And a separate large trial using continuous ECG monitoring in people aged 70 and older found no reduction in stroke hospitalizations in the screened group compared with usual care.⁸ Researchers have gone back and forth on this for years. The prevailing view is that screening helps most when it targets people at higher stroke risk, not necessarily every adult who owns a blood pressure cuff.

Who Benefits Most From an AFib-Detecting Monitor

You do not need a monitor with an AFib symbol if you are 30, healthy, and checking your blood pressure out of curiosity. These devices earn their keep in people who already have risk factors for atrial fibrillation and, more to the point, risk factors for stroke from AFib. That overlapping category includes people over 65, those with high blood pressure, people with diabetes, and those with a history of heart failure or prior cardiovascular events.

A study specifically aimed at older adults and people aged 60 to 65 with hypertension, diabetes, or cardiovascular disease tested a pocket-sized cuffless blood pressure device with an AFib detection algorithm. When the researchers required at least three out of five readings to flag AFib, the device achieved 100 percent sensitivity and 94 percent specificity in that group.⁹ That population is precisely the group where catching silent AFib has the highest payoff, because they are the same people most likely to benefit from blood thinners if AFib is confirmed.

For younger, lower-risk individuals, the math changes. AFib is uncommon in people under 50 without heart disease, and the base rate matters. When a condition is rare in your age group, even a highly specific test will produce more false alarms than true positives, simply because there are so many more people without the condition than with it. If you are young and healthy and your monitor has an AFib symbol, a single isolated alert is far more likely to be noise than a real problem.

Monitors With Built-In ECG

Some newer blood pressure monitors go beyond oscillometric algorithms and include a small built-in electrocardiogram sensor. Omron, for example, has released models where you place your fingers on metal electrodes on the device’s surface while the cuff measures your blood pressure, capturing a single-lead ECG at the same time. This gives the device actual electrical heart data rather than relying solely on pulse-wave timing.

In a study of one such device, the automated ECG algorithm had 100 percent sensitivity and 86 percent specificity for detecting possible AFib. When a physician reviewed the same ECG tracings, the sensitivity was 99 percent and the specificity 85 percent.¹⁰ The accuracy is in the same general range as the cuff-only devices, which might seem surprising. The advantage is that these monitors can save the ECG tracing, letting your doctor see an actual rhythm strip rather than just a symbol on a screen. That strip can sometimes be enough to start treatment without requiring a separate cardiology visit for monitoring.

These ECG-equipped monitors cost more, typically two to three times the price of a standard AFib-detecting blood pressure cuff. Whether that premium is worth it depends on your situation. If you have known paroxysmal (occasional) AFib and your doctor wants you to capture tracings during episodes, a built-in ECG device can be genuinely useful. If you are primarily interested in blood pressure tracking with AFib screening as a bonus, a validated cuff-only device is likely sufficient.

Blood Pressure Accuracy During AFib

There is an issue people rarely think about until the symbol appears: can you trust the blood pressure reading itself if the monitor is flagging an irregular rhythm? The answer is “sort of.” Oscillometric monitors assume a reasonably regular heartbeat to calculate pressure. When the rhythm is chaotic, as in AFib, the algorithm has less stable data to work with, and readings can be less reliable.

Studies comparing automated cuff readings to invasive arterial blood pressure measurement during arrhythmias, most of which involved atrial fibrillation, have shown that automated monitors tend to produce somewhat wider agreement limits during irregular rhythms than during normal sinus rhythm.¹¹ In plain terms, the readings are still in the right ballpark but may be off by a larger margin than usual. The practical workaround is the same one doctors already recommend: take multiple readings and average them. If your monitor is consistently showing the AFib symbol, mention that to your doctor when discussing your blood pressure numbers, so they can account for the extra noise in the measurements.

The Psychological Side of False Alerts

Getting an unexpected health alert from a device can be unsettling, and the research bears this out. A study on smartwatch AFib alerts, which use a similar screening concept, found that people who received a false AFib alert reported a meaningful drop in their sense of physical well-being and less confidence in managing their own symptoms compared with people who never received an alert.¹² People who received more than two false alerts were hit harder, reporting a greater decline in both well-being and self-management confidence compared with those who received only one or two.

Blood pressure monitors are somewhat less likely than smartwatches to bombard you with repeated alerts, because you take discrete readings rather than wearing the device continuously. Still, the emotional dynamic is real. If you know you tend to be anxious about health, consider two strategies. First, understand the false-positive rate upfront so an alert does not catch you off guard. Second, make a plan with your doctor in advance: agree on how many repeat readings you will take before calling the office, so you have a protocol rather than a panic response. That small amount of structure can go a long way toward keeping the screening benefit without the psychological cost.

Choosing a Validated Device

Not every blood pressure monitor with a heart-shaped icon on the box has been clinically validated for AFib detection. The word “validated” here means the device has been tested head-to-head against an electrocardiogram in a published clinical study, following an internationally recognized testing protocol. The Microlife BP B3 AFIB, for example, has passed the ANSI/AAMI/ISO 81060-2:2019 validation protocol for blood pressure accuracy and has had its AFib algorithm tested in multiple independent studies.¹³ Omron’s Complete series and certain Withings devices have similarly undergone published clinical testing.

When shopping for a monitor, look for specific claims about AFib detection validation on the product page or in the user manual, including references to published studies. A device that vaguely mentions “irregular heartbeat detection” without specifying AFib, or that has no published clinical validation data, is probably offering only the generic IHB indicator. There is nothing wrong with that feature, but it should not be confused with the more targeted AFib screening that validated devices provide. If you are buying a monitor specifically for AFib screening, choose one with published sensitivity and specificity numbers you can verify, not just marketing language.